SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-22-000129
Filing Date
2022-11-04
Accepted
2022-11-04 16:08:35
Documents
16
Period of Report
2022-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-20221101.htm   iXBRL 8-K 59576
2 EX-10.1 exhibit101-taxmattersagree.htm EX-10.1 242519
3 EX-99.1 proformafinancialsq222ex99.htm EX-99.1 349288
7 tma-1.jpg GRAPHIC 139335
8 tma-2.jpg GRAPHIC 144750
  Complete submission text file 0000886163-22-000129.txt   1234467

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20221101.xsd EX-101.SCH 1909
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20221101_lab.xml EX-101.LAB 24132
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20221101_pre.xml EX-101.PRE 12516
10 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20221101_htm.xml XML 10864
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 221362431
SIC: 2834 Pharmaceutical Preparations